Department of Health Home A to Z Topics About the Department of Health Site Map Contact Us - Opens in a new window

Epidemiology Home

Health Topics (A-Z)

Related Links

Contact Us

   

DOHLOGO.GIF (7396 bytes)EPI UPDATE

A weekly publication by the Bureau of Epidemiology

For October 8, 1999

"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."

--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.

Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist

Don Ward, Surveillance Section Administrator, Epi Update Managing Editor

Jill H. Parker, MSP, Epi Update Editor

Bureau of Epidemiology Frequent Contributors:

Steven Wiersma, MD, MPH,

Deputy State Epidemiologist

William J. Bigler, PhD, MS,

Senior Epidemiologist

Jodi Baldy, MPH,

Biological Scientist IV

Ursula E. Bauer, PhD,

Chronic Disease Epidemiologist

John Werth, MA,

Bureau Education Coordinator

Lisa Conti, DVM, MPH,

State Public Health Veterinarian

Regional Epidemiologists:

Dolly Katz, PhD, MPH,

SE Florida

Roger Sanderson, RN, MA,

SW Florida

Carina Blackmore, MS Vet. Med., PhD,

NE Florida Carina Blackmore, MS Vet. Med., PhD,

Zuber Mulla, MSPH,

Central Florida Carina Blackmore, MS Vet. Med., PhD,

Gérard Krause, MD, DTMH,

NW Florida

Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.

The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.

Thanks to All Who Participated in the

Sixth Annual Statewide Epidemiology Seminar!

Approximately 200 public health professionals attended the Sixth Annual Statewide Epidemiology Seminar, which was held last week at the Belleview Biltmore Hotel in Pinellas County. We didn't see or hear any ghosts this year at the historic hotel, but interesting speakers and inquisitive minds were everywhere! Thanks to all who participated in making the seminar a success! We look forward to seeing you at the Seventh Annual Statewide Epidemiology Seminar!

In this issue:

1. Regional Meetings for County Health Departments

2. Reporting Procedures for Streptococcus pneumoniae

3. Control of Meningococcal Disease: Suggested Internet Resources

4. Important News About the Epi Update

5. Updated ACIP Statement on Hepatitis A

6. International Symposium on Viral Hepatitis and Liver Disease

7. Fall/Winter 1999 Issue of Immunization and Hepatitis B Publication Available on the Internet

8. Rabies Alert Map and Updated Equine EEE Map

9. Southeast Regional Public Health and Pest & Vector Management Conference

10. The Florida State Tuberculosis Lecture Series: The Rapid Diagnosis of TB: The Role of Nucleic Acid Amplification"

11. Additional Internet Resources

12. Florida Past: Eustis Girl Chosen Nation's Healthiest

13. Weekly Disease Table: Week 39

 

1. Regional Meetings for County Health Departments

The Bureau of Epidemiology is beginning a series of regional meetings about current topics in disease prevention for county health departments. The first meeting is scheduled November 3rd and 4th for the counties in the Panhandle region (counties west of, and including, Madison and Taylor Counties). However, staff from counties outside of the Panhandle region are also welcome to attend. Future meetings will be scheduled for the other regions of the state.

The regional meeting agenda will include: an overview of disease surveillance in Florida, an overview of how to investigate an outbreak (including an opportunity to participate in an outbreak investigation scenario), an update on disease reporting requirements, an overview of Epi Info software capabilities, and a rabies update.

Additional information regarding these regional meetings will be mailed to each county health department within the next few weeks.

2. Reporting Procedures for Streptococcus pneumoniae

Don Ward, Surveillance Section Administrator

(The following article appeared in the Epi Update on July 23, 1999. We have received many calls requesting clarification of the reporting procedure, so we are reprinting the article.)

On July 4, 1999, all invasive Streptococcus pneumoniae infections became reportable. Infections caused by Streptococcus pneumoniae are among the leading causes of illness and death for young children. Annually, in the United States, pneumonococcal disease results in 50,000 cases of bacteremia and 3,000 cases of meningitis. By extrapolation, Florida should expect about 3750 cases of pneumococcal bacteremia and 225 cases of meningitis (121 cases were reported in 1996).

A critical issue in the management of infections caused by S. pneumoniae is the increasing drug resistance of the organism. Research in parts of the U.S. has demonstrated a growing resistance to penicillin and other commonly prescribed drugs. This drug resistance may have developed as a result of indiscriminate or inappropriate prescription or by natural mutation of the organism. Regardless, the extent (and type) of drug resistance to S. pneumoniae in a community offers critical information to physicians treating the disease. In addition to local surveillance, state data are summarized at the national level to provide valuable insights into drug resistance patterns for the country. The important surveillance issue for invasive Streptococcus pneumoniae is to monitor the percent of drug resistant organisms among all invasive S. pneumoniae organisms. In order to do so, it is necessary to collect reports of all invasive S. pneumoniae.

County health departments will report Streptococcus pneumoniae according to the following procedure:

  1. Invasive Drug Resistant Streptococcus pneumoniae, (DRSP) will be reported on a 2016 and accompanied by a DRSP case report form (to be provided by the Bureau of Epidemiology).
  2. Invasive Non-Drug Resistant Streptococcus pneumoniae will not be reported on a 2016, nor will a case report form be completed. In order to report non-drug resistant S. pneumoniae, county health departments should forward the results of all laboratory tests from sterile sites (see case definition) that are positive for S. pneumoniae (except, of course those that are drug resistant, reportable above) to the Surveillance Section in the Bureau of Epidemiology. It is essential that the site from which the specimen was taken is noted on all positive laboratory reports.

Using these data, the Bureau will maintain ongoing surveillance for DRSP in the state and will inform county health departments of the results of that surveillance.

Please direct any questions regarding this reporting procedure to Don Ward, Surveillance Section Administrator at (850) 410-3319, Suncom 210-3319

3. Control of Meningococcal Disease: Suggested Internet Resources

Steven Wiersma, MD, MPH, Deputy State Epidemiologist

ACIP Guidelines, as outlined in MMWR, RR-5, February 14, 1997 ftp://ftp.cdc.gov/pub/Publications/mmwr/rr/rr4605.pdf

4. Important News About the Epi Update

The deadline for submission of articles to the Epi Update has been changed from noon on Wednesday to noon on Tuesday of the week for which they are intended to be published. The complete list of article submission guidelines is as follows:

  • All articles are due no later than Tuesday at noon of the week for which they are intended to be published.
  • Articles must be submitted to Epi Update in final form. If medical or policy reviews will be required (such as by Drs. Hopkins or Wiersma), those reviews must be completed prior to submission.
  • The editors reserve the right to make minor changes in articles to ensure consistency with Epi Update editorial conventions.
  • Please type articles in Arial (regular) 11 point font; do not add centering, boxes, bolding, fancy fonts, etc. Check the spelling prior to submission and have someone else proofread your writing if at all possible.
  • Title your article and add your name/title (as you would like to be credited for the article) at the top of each article submitted.
  • Please send graphs, charts, and other data as attachments even if they are already part of your article. These items must be imported separately when posting the Epi Update to the Internet.
  • Articles submitted via e-mail must be saved as attachments to the e-mail message. Please do not include your article within your e-mail message.
  • All final articles (ready for formatting) should be submitted to Jill H. Parker prior to the Tuesday deadline.

We understand that there may be exceptions to these guidelines. Referrals to websites, other publications and brief announcements can still be e-mailed with your comments and/or suggestions.

Thank you for your attention to these guidelines.

5. Updated ACIP Statement on Hepatitis A

(The following information appeared in the IAC Express #116 (serial online), October 4, 1999, published by the Immunization Action Coalition)

October 1, 1999

CDC PUBLISHES UPDATED ACIP STATEMENT ON HEPATITIS A

On October 1, 1999, the Advisory Committee on Immunization Practices (ACIP) released the updated statement, "Prevention of Hepatitis A Through Active or Passive Immunization." This report includes new information which builds on the earlier recommendations for the use of hepatitis A vaccine which were published in 1996.

The "Summary" statement for this recommendation reads as follows:

Routine vaccination of children is the most effective way to reduce hepatitis A incidence nationwide over time. Since licensure of hepatitis A vaccine in 1995, this strategy has been implemented incrementally, starting with the recommendation of the Advisory Committee on Immunization Practices (ACIP) in 1996 to vaccinate children living in communities with the highest rates of infection and disease. These updated recommendations represent the next phase of this hepatitis A immunization strategy. Vaccination of children living in states and communities with consistently elevated rates of hepatitis A will provide protection from disease and is expected to reduce the overall incidence of hepatitis A.

This report updates the ACIP's 1996 recommendations on the prevention of hepatitis A through immunization (MMWR 1996;45: [No. RR-15]) and includes a) new data about the epidemiology of hepatitis A; b) recent findings about the effectiveness of community-based hepatitis A vaccination programs; and c) recommendations for the routine vaccination of children in states, counties, and communities with rates that are twice the 1987-1997 national average or greater (i.e., greater than or equal to 20 cases per 100,000 population) and consideration of routine vaccination of children in states, counties, and communities with rates exceeding the 1987-1997 national average (i.e., greater than or equal to 10 but less than 20 cases per 100,000 population). Unchanged in this report are previous recommendations regarding the vaccination of persons in groups at increased risk for hepatitis A or its adverse consequences and recommendations regarding the use of immune globulin for protection against hepatitis A.

Editor's Note: Florida does not have any counties with rates twice the 1987-1997 national average and only two counties with rates that exceed the 1987-1997 national average.

6. International Symposium on Viral Hepatitis and Liver Disease

(The following information appeared in IAC Express #115 (serial online), September 28, 1999, published by the Immunization Action Coalition)

The 10th International Symposium on Viral Hepatitis and Liver Disease will be held April 9-13, 2000, in Atlanta, Georgia. This meeting is sponsored by the U.S. Public Health Service in collaboration with the World Health Organization and hosted by the Centers for Disease Control and Prevention. To take advantage of the discounted fee offered to early registrants, you must sign up before December 1, 1999.

7. Fall/Winter 1999 Issue of Immunization and Hepatitis B Publication Available on the Internet!

(The following information appeared in IAC Express #113 (serial online), September 22, 1999, published by the Immunization Action Coalition.)

The Immunization Action Coalition has just released the fall/winter 1999 issue of "VACCINATE ADULTS!" and it is available on their Internet web site. Here are a few tips to help you navigate the information:

To download a camera-ready copy (PDF format) of the entire fall/winter 1999-2000 issue (408,135 bytes), click here: http://www.immunize.org/va/va5.pdf

If you are unable to download the entire issue of "VACCINATE ADULTS!" or its table of contents, see the article below for links to view and/or download individual items you wish to read.

8. Rabies Alert Map (January through September 28, 1999) and Updated Equine EEE Map (January through September 30, 1999)

Lisa Conti, DVM, MPH, State Public Health Veterinarian

Attached is the updated rabies alert map and equine EEE map. Should you have difficulties accessing these files, please contact Jill H. Parker.

Issued Rabies Alerts Map

EEE in Horses Map

9. Southeast Regional Public Health Pest & Vector Management Conference

John P. Smith, Ph.D., B.C.E., Professor & Director, JAMS Public Health Entomology Research & Education Center, Florida A&M University

February 22-24, 2000

Panama City Beach, Florida

The John A. Mulrennan, Sr. Public Health Entomology Research and Education Center of Florida A&M University announces the fourth annual meeting of the Southeast Regional Public Health Pest & Vector Management Conference which is scheduled for February 22-24, 2000. The conference will be held at the Sheraton Four-Point - Boardwalk Beach Resort, Panama City Beach, Florida. The conference offers a wide variety of continuing education topics tailored for environmental, public health, pest and mosquito control professionals. This year's conference starts with an opening half-day plenary session followed by two and a half days of concurrent hands-on workshops.

The purpose of the conference is to provide experiential learning opportunities through hands-on laboratory and field workshops for professionals engaged in the identification, biology, ecology, surveillance and control of arthropods, wildlife and associated zoonotic diseases of public health importance. Attendees can expect to become better prepared in conducting public health pest and vector control programs within their jurisdiction. Continuing education credits will be available in public health, commercial and limited governmental pest control as well as, environmental health for Florida and surrounding states.

10. The Florida State Tuberculosis Lecture Series: The Rapid Diagnosis of TB: The Role of Nucleic Acid Amplification"

(The following information was received from Yvonne Brown, A.G. Holley State Tuberculosis Hospital)

Date:         Wednesday, October 27, 1999

                        12:00 Noon to 2:00 P.M.

Location: A.G. Holley State Tuberculosis Hospital

                        1199 West Lantana Road

                        Lantana, Florida 33462 (I-95 South, Exit 46, East one block)

Topic: The Rapid Diagnosis of TB: The Role of Nucleic Acid Amplification

Speaker: Antonio Catanzaro, MD, Professor of Medicine, University of California, San Diego Treatment Center

  • CMEs and CEUs provided
  • Pre-registration is required, please call (561) 540-3783 or fax to (561) 540-3788
  • Anyone needing interpreters or other disability related accommodations should call or fax the request to the above number prior to October 26, 1999.
  • Jointly sponsored by the American Thoracic Society and the American Lung Association of Florida, Inc.

11. Additional Internet Resources:

CDC's web site now contains info on West Nile virus
http://www.cdc.gov/ncidod/dvbid/westnile/q&a.htm

12. Florida Past - Eustis Girl Chosen Nation’s Healthiest

William J. Bigler, PhD

According to the Florida Times Union (December 1, 1929), on Thanksgiving of that year Miss Mary A. Stennis, extension nurtitionist, Dr. F.A. Brink (Director of Communicable Disease) and Dr. F. L. Fort of the State Board of Health made the final examinations of contestants that would represent Florida in the National Four-H Congress Annual Health Contest in Chigago. Miss Florence Smock was selected as the state’s entrant and after the dust settled, Miss Smock and Harold Deatline, an Indiana farm boy, were named Health Champions of the United States. Excerpts from an AP article on December 4, 1929 that was picked up by the Miami Herald and St. Augustine Evening Record follow.

The healthiest girl in the United States, as reckoned by the Four-H Club Annual Congress, is 17 years old, weighs 129 pounds, stands 5 feet 1/2 inches in her medium heel shoes,...is Florence Smock....Miss Smock who hails from Eustis, Florida...is a junior in the high school there...Brown eyes, with hair to match, and a small delicate nose, set off her oval, smiling face..." The healthiest girl," swims, dances and occasionally "has dates," she said "but nine o’clock is bedtime every night, just as 7 a. m. is "getting up time." Florence uses no rouge nor lipstick, but has rosy cheeks... she wants to be a physical education teacher...is a senior lifesaver in the Red Cross and has been in the Four-H Club ...two and one-half years, specializing in home improvement, nutrition and health.

Miss Smock thought that perhaps she was healthy because of "Florida sunshine - and oranges," but with the sunshine and oranges went regular hours, ten hours of sleep and plenty of exercise.

13. Weekly Disease Table: Week 39

County-Confirmed Cases, Sorted Alphabetically by Disease

(NR represents years that the disease lacked status as a reportable condition)

DISEASE

1996 TO DATE

1997 TO DATE

1998 TO DATE

3 YEAR AVERAGE

TO DATE

1998 TOTAL CASES

1999 TO DATE

Amebiasis

59

41

49

49.7

91

39

Anthrax

0

0

0

0

0

0

Botulism

0

0

0

0

0

3

Brucellosis

5

0

3

2.7

3

1

Campylobacteriosis

878

737

576

730.3

975

681

Ciguatera

12

6

7

8.3

7

2

Cryptosporidiosis

203

100

118

140.3

203

107

Cyclosporiasis

183

65

6

84.7

6

3

Dengue

0

3

3

2

5

4

Diphtheria

0

0

0

0

0

0

E. coli O157:H7

25

39

32

32

57

45

E. coli, other (known serotype)

5

5

4

4.7

12

13

Ehrlichiosis, Human

4

2

0

2

1

1

Encephalitis, Eastern Equine

1

2

0

1

0

2

Encephalitis, St. Louis

0

1

0

0.3

2

0

Encephalitis, other (known organism)

5

9

4

6

7

3

Encephalitis, post-infectious1

13

8

10

10.3

21

6

Giardiasis (acute)

1408

1155

1036

1199.7

1636

840

Haemophilus influenzae, invasive1

16

19

32

22.3

45

35

Hansen’s Disease (Leprosy)

1

0

4

1.7

4

3

Hantavirus Infection

0

0

0

0

0

0

Hemolytic Uremic Syndrome

0

3

9

4

12

7

Hemorrhagic Fever

0

0

0

0

0

0

Hepatitis A

345

386

372

367.7

538

508

Hepatitis B

371

281

296

316

466

311

Hepatitis C2

NR

NR

NR

NR

NR

42

Hepatitis Non-A, Non-B

61

68

64

64.3

94

10

Hepatitis, perinatal B2

NR

NR

NR

NR

NR

3

Hepatitis, unspecified

3

6

13

7.3

27

10

Hepatitis, +HBsAg, pregnant woman2

NR

NR

NR

NR

NR

25

Lead Poisoning

1437

1050

1348

1278.3

1805

564

Legionellosis

29

18

24

23.7

48

19

Leptospirosis

0

0

1

0.3

2

0

Listeriosis2

NR

NR

NR

NR

NR

21

Lyme Disease

16

24

33

24.3

71

31

Malaria

65

59

45

56.3

96

63

Measles

1

3

2

2

2

2

Meningococcal Disease (N. meningitidis)

145

115

98

119.3

133

85

Meningitis, Group B Streptococci

21

12

14

15.7

22

12

Meningitis, Haemophilus influenzae1

6

8

11

8.3

12

12

Meningitis, Streptococcus pneumoniae

79

60

63

67.3

96

76

Meningitis, Listeria monocytogenes

5

2

4

3.7

13

8

Meningitis, other bacterial (including unspecified)

79

45

43

55.7

75

52

Mercury Poisoning

6

2

0

2.7

4

2

Mumps

8

8

10

8.7

11

4

Neurotoxic Shellfish Poisoning2

3

0

0

1

0

0

Pertussis

78

54

34

55.3

39

64

Pesticide Poisoning

1

0

1

0.7

1

1

Plague

0

0

0

0

0

0

Poliomyelitis

0

0

0

0

0

0

Psittacosis

0

0

1

0.3

2

0

Rabies, Animal

183

216

156

185

215

148

Rocky Mountain Spotted Fever

1

2

1

1.3

2

1

Rubella, including congenital

10

3

3

5.3

4

0

Salmonellosis

1746

1501

1799

1682

3038

1829

Shigellosis

1086

991

1605

1227.3

2343

1030

Smallpox2

NR

NR

NR

NR

NR

0

Staphlococcus aureus, (GISA/VISA)2

NR

NR

NR

NR

NR

0

Staphlococcus aureus, (GRSA/VRSA)2

NR

NR

NR

NR

NR

0

Streptococcal Disease, invasive Group A

3

28

35

22

57

53

Streptococcus pneumoniae, invasive disease

9

150

316

158.3

493

457

Tetanus

2

1

2

1.7

3

2

Toxic Shock Syndrome

0

1

4

1.7

4

6

Toxoplasmosis

8

4

9

7

15

13

Typhoid Fever

20

8

12

13.3

16

23

Vibrio cholerae (serogrp O1)

0

0

0

0

0

1

Vibrio cholerae (serogrp Non-O1)

2

7

6

5

11

8

Vibrio vulnificus

8

13

23

14.7

35

14

Vibrio other (including unspecified)

17

22

55

31.3

73

33

Yellow Fever

0

0

0

0

0

0

1 Haemophilus influenzae can be the agent responsible for disease under three of the reportable conditions listed-: "Haemophilus influenzae, invasive" and under "Encephalitis, post infectious." Cases of Haemophilus influenzae meningitis are reported under "Meningitis, H. influenzae."

2 The reportable disease rule was revised in July, 1999. Kawasaki Disease, Histoplasmosis, Reye Syndrome, and Typhus were deleted from the weekly disease table since cases are no longer reportable as of July 4, 1999. Hepatitis C; perinatal hepatitis B; hepatitis B +HbsAg, pregnant woman; listeriosis; smallpox, S. aureus (GISA/VISA) and S. aureus (GRSA/VRSA) were added to the reporting requirements as of July 4, 1999. Paralytic shellfish poisoning is now referred to as neurotoxic shellfish poisoning.

This page was last modified on: 10/26/2012 09:27:35